Congratulations to first author Super-Star @BraunMDPhD and to all authors. #CathyWu #SachetShukla @LabSignoretti @VanAllenLab #FreemanLab #SharpeLab
@DanaFarberNews @DanaFarber
#kcsm #KidneyCancer
doi.org/10.1038/s41591…
![](https://pbs.twimg.com/media/EZNyKueUwAAZjjT.png)
![](https://pbs.twimg.com/media/EZNzkhuUcAAMReK.png)
![](https://pbs.twimg.com/media/EZNzmwIUMAAS9hw.png)
![](https://pbs.twimg.com/media/EZNzotiUMAAINZ-.png)
![](https://pbs.twimg.com/media/EZNzqd4UcAA-U4d.png)
![](https://pbs.twimg.com/media/EZN0r7TUcAA42Z-.png)
![](https://pbs.twimg.com/media/EZN1qbGVAAAXRZE.png)
![](https://pbs.twimg.com/media/EZN1tCoU0AA3BAK.png)
![](https://pbs.twimg.com/media/EZN1udeU8AAitX_.png)
•@sarahAbouAlaiwi, @CIR 2020 cancerimmunolres.aacrjournals.org/content/early/…: Oncopanel data: SWF/SNF alternations have no effect on IO outcomes. Exceptions: RCC: association with TTF, OS
•Vano, ASCO GU 2020, HR OS 0.59 in PBRM1 loss by IHC (France), @LAlbiges
•City of Hope, AACR 2020 (HR<1, in CB pts, p=0.2) @montypal @NazliDizman (small cohort)